Maternal obesity impairs brain glucose metabolism and neural response to hyperglycemia in male rat offspring
Post on 24-Mar-2017
Embed Size (px)
*School of Medical and Molecular Biosciences, Faculty of Science, Centre for Health Technology,
University of Technology, Sydney, NSW, Australia
Department of Pharmacology, School of Medical Sciences, University of New South Wales, Sydney,
Inflammation and Infection Research, School of Medical Sciences, University of New South Wales,
Sydney, NSW, Australia
AbstractHypothalamic appetite regulators neuropeptide Y (NPY) andpro-opiomelanocortin (POMC) are modulated by glucose.This study investigated how maternal obesity disturbs glu-cose regulation of NPY and POMC, and whether thisderegulation is linked to abnormal hypothalamic glucoseuptake-lactate conversion. As post-natal high-fat diet (HFD)can exaggerate the effects of maternal obesity, its additionalimpact was also investigated. Female Sprague Dawley ratswere fed a HFD (20 kJ/g) to model maternal obesity. Atweaning, male pups were fed chow or HFD. At 9 weeks, invivo hypothalamic NPY and POMC mRNA responses toacute hyperglycemia were measured; while hypothalami wereglucose challenged in vitro to assess glucose uptake-lactaterelease and related gene expression. Maternal obesitydampened in vivo hypothalamic NPY response to acute
hyperglycemia, and lowered in vitro hypothalamic glucoseuptake and lactate release. When challenged with 20 mMglucose, hypothalamic glucose transporter 1, monocarboxy-late transporters, lactate dehydrogenase-b, NPY and POMCmRNA expression were down-regulated in offspring exposedto maternal obesity. Post-natal HFD consumption reducedin vitro lactate release and monocarboxylate transporter 2mRNA, but increased POMC mRNA levels when challengedwith 20 mM glucose. Overall, maternal obesity producedstronger effects than post-natal HFD consumption to impairhypothalamic glucose metabolism. However, they both dis-turbed NPY response to hyperglycemia, potentially leading tohyperphagia.Keywords: GLUT1, lactate production, MCTs, mTOR, NPY,POMC.J. Neurochem. (2014) 129, 297303.
Traditionally, glucose-responsive neurons are defined as thosethat increase their action potential frequency when ambientglucose is increased above resting levels (up to 1020 mmol/L), whereas glucose-sensitive neurons decrease their actionpotential frequency under the same conditions (Song et al.2001). In this regard, in the hypothalamic arcuate nucleus(Arc), neurons expressing orexigenic neuropeptide Y (NPY)are inhibited by rising glucose levels, while neurons express-ing anorexigenic pro-opiomelanocortin (POMC) are excitedby glucose abundance (Muroya et al. 1999; Ibrahim et al.2003; Stefater and Seeley 2010). Mammalian target ofrapamycin (mTOR) can sense changes in ambient glucoseand amino acid levels; a function that is critical for regulationof cellular activity. mTOR is colocalized in NPY- and POMC-expressing cells (Cota et al. 2006), suggesting mTOR may
play an important role in NPY and POMC neural glucosesensing and changes in their mRNA expression. Indeed, theshort-term activation of mTOR can inhibit NPY expression to
Received April 3, 2013; revised manuscript received November 6, 2013;accepted November 21, 2013.Address correspondence and reprint requests to Hui Chen, School of
Medical and Molecular Biosciences, Faculty of Science, University ofTechnology, Sydney, NSW 2007, Australia. E-mail: email@example.com; Margaret J. Morris, Department of Pharmacology, School ofMedical Sciences, University of New South Wales, Sydney, NSW 2052,Australia. E-mail: firstname.lastname@example.orgAbbreviations used: Arc, arcuate nucleus; GLUT, glucose transporter;
HFD, high-fat diet; IPGTT, intraperitoneal glucose tolerance test; LDH,lactate dehydrogenase; MCT, monocarboxylate transporter; mTOR,mammalian target of rapamycin; NPY, neuropeptide Y; POMC, pro-opiomelanocortin; PVN, paraventricular nucleus; TG, triglyceride.
2013 International Society for Neurochemistry, J. Neurochem. (2014) 129, 297--303 297
JOURNAL OF NEUROCHEMISTRY | 2014 | 129 | 297303 doi: 10.1111/jnc.12623
reduce energy intake and body weight (Cota et al. 2006).High-fat diet (HFD) consumption can impair brain mTORactivation, leading to overeating in rodents (Um et al. 2006;Cota et al. 2006).We previously showed that maternal obesityis also linked to deregulation of both hypothalamic mTOR andNPY expression, contributing to hyperphagia and obesity inoffspring (Chen and Morris 2009; Chen et al. 2012).It has been suggested that brain glucose sensing activity by
mTOR relies on the ATP generated from glucoselactatepyruvate conversion (Stefater and Seeley 2010). In astro-cytes, glucose is taken up and can be further metabolizedanaerobically into lactate, which is transferred to neurons tosupply fuel (Magistretti 2006), in addition to the directglucose uptake by neurons from the extracellular space. Inneurons, lactate is further metabolized into pyruvate throughlactate dehydrogenase (LDH)b (Lam et al. 2007). Thisprocess can not only induce appetite suppression, but canalso lower blood lipid and glucose levels through amechanism involving the liver (Lam et al. 2008; Lam2007; Lam et al. 2005). Therefore, altered central glucosemetabolism may potentially lead to abnormal glucoseregulation of NPY and POMC-expressing neurons, and thusappetite deregulation. We have previously shown thathypothalamic mTOR expression and activity are significantlydown-regulated by maternal obesity (Chen et al. 2008,2012). It is not known whether this is linked to abnormalhypothalamic glucose sensing and metabolic ability. Thisformed one of the rationales of this study.We have observed that a change in blood glucose level
(hypoglycemia) led to hyper-activation of hypothalamicNPY expression in offspring from obese dams compared tooffspring from lean mothers (Chen and Morris 2009). Studieshave also reported impaired glucose sensing under lowglucose conditions in both genetic and dietary obese ratmodels, as well as in rat models of maternal overnutrition(Fuente-Martin et al. 2012; Song et al. 2001; Parton et al.2007; Canabal et al. 2007). However, it is unknown whethermaternal obesity leads to impaired hyperglycemia-inducedregulation of NPY and POMC (Sarbassov et al. 2005). Wehypothesized that hypothalamic glucose metabolism wasimpaired by maternal obesity, which further leads toderegulated hypothalamic NPY and POMC expression inresponse to hyperglycemia. In addition, these alterations canbe further exacerbated by post-natal HFD consumption.Therefore, we aimed to determine the effect of maternalobesity and post-natal HFD on the mRNA expression ofhypothalamic NPY and POMC during hyperglycemia in vivoand under increased ambient glucose level in vitro.
Materials and method
All procedures were approved by the Animal Care and EthicsCommittee of the University of New South Wales. Female
SpragueDawley rats (8 weeks, Animal Resource Centre, Yanderra,WA, Australia) were assigned to two groups, one fed a pelleted HFD(n = 15, 20 kJ/g, 43% fat; SF03-020, Specialty Feeds, Glen Forrest,WA, Australia) to induce obesity, and a control group fed standardrodent chow (n = 10, 11 kJ/g, 14% fat, Gordons Specialty Stock-feeds, NSW, Australia) for 6 weeks prior to mating, throughoutgestation and lactation (Chen et al. 2012). At post-natal day 1, littersizes were adjusted to 1012 pups/litter (sex 1 : 1). At 20 days,within each litter half of the male pups were fed chow and the otherhalf were fed HFD. This yielded four groups, male offspring fromchow-fed dams consuming chow (CC) or HFD (CH), and maleoffspring from HFD-fed dams consuming chow (HC) or HFD (HH).There were 23 pups from the same litter within each group.Intraperitoneal glucose tolerance test (IPGTT) was performed at8 weeks (n = 68 in each group) (Chen et al. 2009). After 5 hfasting, baseline glucose (T0) was measured using tail tip blood(Accu-Chek glucose meter, Roche Diagnostics, Nutley, NJ, USA).Blood glucose levels were measured at 15, 30, 60, and 90-min post-glucose injection (2 g/kg, i.p.). Area under the curve (AUC) wascalculated for each rat using the equation 0.5 9 (GT0 + GT15)9 15 min + 0.5 9 (GT15 + GT30) 9 15 min + 0.5 9 (GT30 +GT60) 9 30 min + 0.5 9 (GT60 + GT90) 9 30 min.
Sample collection and analysis
At 9 weeks, offspring were fasted for 5 h then anesthetized withPentothal (0.1 mg/g, i.p., Abbott Australasia Pty. Ltd., Lane Cove,NSW, Australia). Half of the rats within each group were injectedwith glucose (0.5 g/kg, i.v.), while the other half received saline ascontrol (n = 56 under each condition). Cardiac blood was collected10 min after injection and glucose levels were measured immedi-ately. The hypothalamic areas containing Arc and paraventricularnucleus (PVN) were isolated (Chen et al. 2009) and stored at80C. Abdominal fat pads (retroperitoneal, mesenteric, andepididymal fat)) and liver were weighed.
Another cohort (9-week old, n = 1112) was anesthetized as aboveand killed in a non-fasting state. Thewhole hypothalamuswas quicklysliced into 440 lm prisms (McIlwain tissue chopper, Mickle Labo-ratory Engineering Co. Ltd. Guildford, Surrey, UK.), then carefullyplaced into individual wells containing 1 mL of modified Krebssolution (containing 5 mM glucose and no lactate as previouslydescribed (Parton et al. 2007; Bertrand et al. 2011). The culture platewas incubated at 37C/5% CO2 in an orbital incubator at 55 rpm(oscillation amplitude 20 mm) and the Krebs solution was replacedevery 20 min. After 1 h equilibration, a basal 20 min samplecollection was performed. Then, the tissues were challenged with20 mM glucose for 20 min. Superfusates were collected, centrifugedand stored at 20C. Brain tissue was kept for later determination ofmRNA expression of NPY, POMC, mTOR, Glucose transporter(GLUT)1, monocarboxylate transporter (MCT)2 and 4, and LDHb.
Plasma triglyceride (TG) was measured using glycerol standard(Sigma,